Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$3.35 - $5.67 $44,735 - $75,717
-13,354 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$4.75 - $6.87 $5,543 - $8,017
-1,167 Reduced 8.04%
13,354 $73,000
Q4 2020

Feb 16, 2021

BUY
$5.35 - $7.77 $20,806 - $30,217
3,889 Added 36.58%
14,521 $78,000
Q3 2020

Nov 12, 2020

BUY
$7.22 - $9.11 $6,765 - $8,536
937 Added 9.66%
10,632 $80,000
Q2 2020

Aug 13, 2020

BUY
$4.93 - $10.26 $47,796 - $99,470
9,695 New
9,695 $84,000
Q1 2020

May 14, 2020

SELL
$2.58 - $6.6 $18,477 - $47,269
-7,162 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$5.02 - $6.66 $35,953 - $47,698
7,162 New
7,162 $37,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $51.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.